IVVD
Invivyd, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.83
−1.08%Margins
Gross margin
91.4%
EBITDA margin
-183.9%
EBIT margin
-192.8%
Net margin
-183.9%
FCF margin
-187.9%
-59.3%
Return on equity
-49.0%
Return on assets
-59.4%
Return on invested capital
0.25x
Asset turnover
-$108.4M
Cash from operations
$0.54
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026